BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Cohance Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (Rs)
117.1064173
NSE Symbol
COHANCE
Divident Yield %
0
Market Cap
(Rs In Cr.)
15,542
P/E (TTM)
62.12
EPS (TTM)
6.54
Face Value
(Rs)
1
Back
Cohance Lifesciences consolidated net profit declines 83.77% in the March 2026 quarter
13-May-26   Hrs IST

Net profit of Cohance Lifesciences declined 83.77% to Rs 19.55 crore in the quarter ended March 2026 as against Rs 120.43 crore during the previous quarter ended March 2025. Sales declined 26.33% to Rs 619.12 crore in the quarter ended March 2026 as against Rs 840.42 crore during the previous quarter ended March 2025.

For the full year,net profit declined 63.22% to Rs 179.23 crore in the year ended March 2026 as against Rs 487.34 crore during the previous year ended March 2025. Sales declined 13.03% to Rs 2268.55 crore in the year ended March 2026 as against Rs 2608.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales619.12840.42 -26 2268.552608.50 -13
OPM %15.9427.27 -18.8230.56 -
PBDT87.65230.82 -62 423.84825.21 -49
PBT36.42176.65 -79 236.51658.41 -64
NP19.55120.43 -84 179.23487.34 -63

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)